RetroVirox Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RetroVirox's estimated annual revenue is currently $930k per year.(i)
  • RetroVirox's estimated revenue per employee is $155,000

Employee Data

  • RetroVirox has 6 Employees.(i)
  • RetroVirox grew their employee count by 0% last year.

RetroVirox's People

NameTitleEmail/Phone
1
Founder and Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is RetroVirox?

RetroVirox is a privately-held CRO exclusively focused on the virology field. RetroVirox offers a broad menu of antiviral assays in a fee-for-service or F.T.E. pricing modality. Tests routinely performed include in vitro infectivity, replication, and neutralization assays to determine the antiviral activity of experimental drugs and evaluate candidate vaccines and antibodies. Assays with over a dozen different viruses have been validated and are offered to our customers. Since inception RetroVirox has helped hundreds of companies to complete the preclinical discovery needs of their antiviral and vaccine candidates. Our customers include small start up Biotechs to large Pharmaceuticals in five continents. RetroVirox is also developing small-molecule programs to enhance the adaptive immune response against HIV, and inhibitors with anti-cancer activity. More information about the antiviral services offered at RetroVirox is available at this link: https://retrovirox.com/Retrovirox_-_An_Integrated_Antiviral_Company.html RetroVirox is headquartered in San Diego, CA.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M6-25%N/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.4M6N/AN/A